True Wealth Design
RVMD icon

True Wealth Design’s Revolution Medicines RVMD Stock Holding History

True Wealth Design’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$35.9K Buy
175
+43
+33% +$8.52K 0.01% 630
2026
Q2 		$24.7K Buy
132
+127
+2,540% +$18.6K 0.01% 738
2026
Q1 		$487 Hold
5
– – ﹤0.01% 2063
2025
Q4 		$399 Sell
5
-1
-17% -$66 ﹤0.01% 2025
2025
Q3 		$281 Buy
6
+1
+20% +$39 ﹤0.01% 2211
2025
Q2 		$184 Buy
+5
New +$192 ﹤0.01% 2098

Other funds holding RVMD

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Loftus Peak Pty Ltd
Loftus Peak Pty Ltd Sydney, Australia $781M AUM
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Wedmont Private Capital
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

True Wealth Design's RVMD Position: Q3 2026 in Review

True Wealth Design increased its Revolution Medicines (RVMD) stake by 33% in Q3 2026, buying an estimated $8.52K and bringing the position to 175 shares worth $35.9K. The position accounts for 0.01% of the portfolio, ranked #630.

True Wealth Design first reported a position in RVMD in Q2 2025 and has held it in 6 quarters since. 146 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • True Wealth Design held 175 shares of Revolution Medicines worth $35.9K as of Q3 2026.
  • True Wealth Design bought 43 Revolution Medicines shares in Q3 2026, an estimated $8.52K.
  • Revolution Medicines made up 0.01% of True Wealth Design's portfolio in Q3 2026, its #630 holding.
  • True Wealth Design first reported a position in Revolution Medicines in Q2 2025 and has held it in 6 quarters since.
  • 146 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.